Evidence map›Paper›PMID 40312695›Full record

ArticleBMC health services research2025

A case study of the co-creation of the PrEP-SIC: a roadmap to support introduction of pre-exposure prophylaxis into new settings.

Kathrine Meyers, Benjamin Lane, Jason Zucker, Yumeng Wu, Caroline Carnevale, Helen Burnside, Sarah Rowan, Eric Mayes, Gilianne Narcisse-Cempini, Melanie A Gold and 2 more

Abstract read
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kathrine MeyersAaron Diamond AIDS Research Center, Hammer Health Sciences, Columbia University, Vagelos College of Physicians and Surgeons, Suite 1108, 701 W. 168th Street, New York, NY, 10032, USA. Kam2157@cumc.columbia.edu.
Benjamin LaneAaron Diamond AIDS Research Center, Hammer Health Sciences, Columbia University, Vagelos College of Physicians and Surgeons, Suite 1108, 701 W. 168th Street, New York, NY, 10032, USA.
Jason ZuckerDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Yumeng WuAaron Diamond AIDS Research Center, Hammer Health Sciences, Columbia University, Vagelos College of Physicians and Surgeons, Suite 1108, 701 W. 168th Street, New York, NY, 10032, USA.
Caroline CarnevaleNewYork-Presbyterian Hospital, New York, NY, USA.
Helen BurnsidePublic Health Institute at Denver Health, Denver, CO, USA.
Sarah RowanPublic Health Institute at Denver Health, Denver, CO, USA.
Eric MayesVirginia Department of Health, Division of Disease Prevention, Richmond, VA, USA.
Gilianne Narcisse-CempiniDivision of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA.
Melanie A GoldDepartment of Pediatrics and Department of Population & Family Health, Columbia University Irving Medical Center, New York, NY, USA.
Lisa SaldanaChestnut Health Systems-Lighthouse Institute, Eugene, OR, USA.
Sarit A GolubDepartment of Psychology, Hunter College of the City University of New York, New York, NY, USA.

Funding

Synthesizing Best Practice to Accelerate Access to Emerging HIV Prevention ModalitiesR01MH123262 · NIMH · HUNTER COLLEGE · PI GOLUB, SARIT A, MEYERS, KATHRINE · 2020 to 2024
$4.2M
Facilitating Sustainment Through Implementation Feedback: The SIC Coaching ModelR01DA044745 · NIDA · OREGON SOCIAL LEARNING CENTER, INC. · PI SALDANA, LISA · 2018 to 2022
$3.8M
National Institute of Drug Abuse R01DA044745NIDA NIH HHS R01 DA044745NIMH NIH HHS R01 MH123262NIMH NIH HHS R01MH123262
6 · The paper itself

Abstract

backgroundPre-exposure prophylaxis (PrEP) is an effective biomedical intervention to prevent HIV, however uptake of PrEP across the United States has been slow and uneven. Understanding "what it takes" to implement PrEP so that it reaches those groups with the highest rates of new diagnoses is a critically important and understudied question. This descriptive case study details the development of an implementation science tool to guide the introduction of PrEP into new settings.

methodsThe Universal Stages of Implementation Completion (U-SIC) was customized for the provision of PrEP services (PrEP-SIC) by using subject matter expert recommendations to operationalize PrEP implementation processes into discreet activities. Six clinical sites used the PrEP-SIC retrospectively and prospectively to assess the extent to which the PrEP-SIC activities mapped onto their experience of introducing oral daily, event-driven, and injectable PrEP into their clinical settings. Interviews with site champions and PrEP-SIC data, including proportion of activities completed, were analyzed to refine the PrEP-SIC and identify patterns of implementation behavior.

resultsFive themes emerged about the accuracy of the PrEP-SIC to capture real world implementation processes: (1) Some PrEP-SIC activities, such as generating a costing plan, are not reflected in real-world implementation; (2) Sites do not define sustainment as achieving a set of quantitative program goals, but rather as being able to continue a program through staffing turnovers and shortages; (3) Written protocols and reviewing clinic data for program improvement were identified as two key factors that differentiate sites that reached sustainment from sites that did not; (4) The PrEP-SIC is assessed as somewhat useful to guide introduction of PrEP, but pairing the tool with technical assistance or coaching would optimize its utility; (5) Implementation is cyclical and recursive and pre-implementation activities may need to be revisited over time to ensure sustainment.

conclusionsThe case study has resulted in a PrEP-SIC that accurately captures an idealized implementation process. Using a well-defined set of implementation activities as a roadmap with supportive services to clinics, like technical assistance or implementation coaching, could direct implementation efforts and facilitate the integration of PrEP into new clinical settings that reach the people who need PrEP the most.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisHumansImplementation ScienceOrganizational Case StudiesProspective StudiesRetrospective StudiesUnited StatesAnti-HIV AgentsClinical servicesHIV preventionImplementation science toolsPre-exposure prophylaxisResearch translation

Identifiers

PMID40312695
PMCPMC12046705

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.